LEA Partners GmbH is a venture capital and private equity firm specializing in seed, early stage, growth, and buyout investments. The firm prefers to invest up to 45m EUR in equity per transaction in companies. It seeks to take majority stake in companies.
leapartners.de/en ↗We invest in software and deep-tech companies that challenge the status quo by building 10x better solutions or disrupting the market. Product-Market fit with traction needed.
Berlin, Germany
WestTech Ventures is a technology-oriented early-stage investor in Berlin. WestTech invests in startups in the pre-seed phase, during founding and building of the company in the seed phase and continues to support the growth stage and the exit. The focus of WestTech is on topics such as: software, software engineering, B2B, SaaS, mobile services, media, media technology and education.
Germany
Senovo is an early-stage VC funding global B2B SaaS category-leaders from Europe in Seed or Series A fundraising rounds. The fund invests into enterprise software startups in the areas of process optimization, industry 4.0 and data-enabled solution. The investor supports tech entrepreneurs in scaling marketing, sales, organisation, finance and KPIs.
Germany
415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation. For over 25 years, our team has been providing exceptional entrepreneurs with capital, expertise, and market access.
Germany
First Momentum Ventures is a pre-seed VC fund for technical B2B and Deep Tech startups in Europe. Our team of engineers and scientists understands technical products and teams, providing comprehensive support from fundraising to recruiting.
San Francisco, Germany
Data Collective is a venture capital fund that invests in the big data and IT infrastructure technology industries. The firm was founded in 2011 and is based in Palo Alto, California with an additional office in San Francisco, California.
Germany
The leading European HealthTech & AI venture capital fund. EUR 200m+ AUM, 27 portfolio companies, 8,000+ ventures evaluated. Investing EUR 1-5m from Pre-Seed to Series A, backed by 25+ health insurers, pharma, and institutional investors.